Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.83 |
| ▸ | HPGD | P15428 | 3/20 | 0.83 |
| ▸ | RAB9A | P51151 | 2/20 | 0.83 |
| ▸ | MMP13 | P45452 | 2/20 | 0.63 |
| ▸ | MAOB | P27338 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | STAT3 | P40763 | 1/20 | 0.59 |
| ▸ | STAT1 | P42224 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | ESRRA | P11474 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.50 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.50 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9999838 | 1.00 | MAPT (0.83) | MAPTHPGDRAB9AMMP13MAOB | |
| SCHEMBL10014131 | 0.94 | HPGD (0.73) | MAPTHPGDRAB9AMMP13MAOB | |
| SCHEMBL10014134 | 0.94 | MAPT (0.73) | MAPTHPGDRAB9AMMP13MAOB | |
| SCHEMBL16995927 | 0.94 | HPGD (0.73) | MAPTHPGDRAB9AMMP13MAOB | |
| SCHEMBL12062003 | 0.94 | HPGD (0.73) | MAPTHPGDRAB9AMMP13MAOB | |
| SCHEMBL24380498 | 0.94 | MAPT (0.73) | MAPTHPGDRAB9AMMP13MAOB | |
| SCHEMBL9999840 | 0.94 | HPGD (0.73) | MAPTHPGDRAB9AMMP13MAOB | |
| SCHEMBL21935265 | 0.94 | MAPT (0.73) | MAPTHPGDRAB9AMMP13MAOB | |
| SCHEMBL22929838 | 0.94 | MAPT (0.73) | MAPTHPGDRAB9AMMP13MAOB | |
| SCHEMBL19413155 | 0.94 | MAPT (0.73) | MAPTHPGDRAB9AMMP13MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368595-A1 | NOVEL MOLECULES | Xeniopro GmbH (DE) | 2025-12-04 | — | — | US | claimed |
| US-20250368595-A1 | NOVEL MOLECULES | Xeniopro GmbH (DE) | 2025-12-04 | — | — | US | disclosed |
| CN-119470907-A | Application of glyoxal-based compound in preparation of probe | 深圳湾实验室 | 2025-02-18 | — | — | CN | disclosed |
| US-12017972-B2 | All-aromatic liquid-crystalline homo-polyimides with aromatic endgroups and crosslinked products therefrom | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2024-06-25 | — | — | US | disclosed |
| US-20230374237-A1 | METHOD FOR IMPREGNATING REINFORCING FIBRES WITH POLYARYLETHERKETONES AND SEMI-PRODUCTS OBTAINED THEREFROM | ARKEMA FRANCE (FR) | 2023-11-23 | — | — | US | disclosed |
| US-11781017-B2 | Blends of polyaryletherketones having improved impact-resistance, elongation at break and flexibility | ARKEMA FRANCE (FR) | 2023-10-10 | — | — | US | disclosed |
| US-11746188-B2 | Poly(aryl-ether-ketone) (PAEK) powder suitable for multiple use in sintering methods | ARKEMA FRANCE (FR) | 2023-09-05 | — | — | US | disclosed |
| US-11697718-B2 | Method for impregnating reinforcing fibres with polyaryletherketones and semi-products obtained therefrom | ARKEMA FRANCE (FR) | 2023-07-11 | — | — | US | disclosed |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | Xeniopro GmbH (DE) | 2023-05-11 | — | — | US | disclosed |
| CN-116018138-A | Substituted 1H-imidazo [1,2-b ] pyrazole-3-carboxamides as inhibitors of brunauer tyrosine kinase | 河南知微生物医药有限公司 | 2023-04-25 | — | — | CN | disclosed |
| US-20070244120-A1 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | BAYER HEALTHCARE LLC | 2007-10-18 | — | — | US | disclosed |
| US-20070164466-A1 | Method for producing filler-containing foam slabs | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-19 | — | — | US | disclosed |
| US-7235576-B1 | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | BAYER PHARMACEUTICALS CORPORATION (US) | 2007-06-26 | — | — | US | disclosed |
| US-7235576-B1 | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | BAYER PHARMACEUTICALS CORPORATION (US) | 2007-06-26 | — | — | US | disclosed |
| WO-2007053574-A2 | COMBINATIONS COMPRISING SORAFENIB AND INTERFERON FOR THE TREATMENT OF CANCER | BAYER PHARMACEUTICALS CORPORATION (US) | 2007-05-10 | — | — | WO | disclosed |
| US-7189782-B2 | Thermoplastic film, thermoplastic resin composition, and phyllosilicate | TEIJIN LIMITED (JP) | 2007-03-13 | — | — | US | disclosed |
| US-7189782-B2 | Thermoplastic film, thermoplastic resin composition, and phyllosilicate | TEIJIN LIMITED (JP) | 2007-03-13 | — | — | US | disclosed |
| US-20070020704-A1 | Diaryl ureas with kinase inhibiting activity | BAYER HEALTHCARE LLC | 2007-01-25 | — | — | US | disclosed |
| US-20070020704-A1 | Diaryl ureas with kinase inhibiting activity | BAYER HEALTHCARE LLC | 2007-01-25 | — | — | US | disclosed |
| US-4536517-A | ANTIDIABETIC, ANTILIPEMIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1985-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070020704-A1 | Diaryl ureas with kinase inhibiting activity | FLT4, FLT1, FLT3 | MAPT 2377/4885HPGD 1866/4885RAB9A 2233/4885 |
| US-20070244120-A1 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | BRAF, RAF1, ARAF | MAPT 3056/4885HPGD 2117/4885RAB9A 1346/4885 |
| US-20250368595-A1 | NOVEL MOLECULES | MUSK, IKZF3, TYR | MAPT 3885/4885HPGD 2438/4885RAB9A 2783/4885 |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | AHR, MUSK, TYR | MAPT 4044/4885HPGD 1353/4885RAB9A 2351/4885 |
| US-12017972-B2 | All-aromatic liquid-crystalline homo-polyimides with aromatic endgroups and crosslinked products therefrom | TPR, AS3MT, ASF1A | MAPT 231/4885HPGD 3121/4885RAB9A 4513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.